MD Medical Group Opens Clinic in Vladimir
MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE:MDMG), a leading Russian private healthcare provider, announces the opening of a new IVF clinic in Vladimir.
Mother and Child Vladimir is the first Group’s clinic in the Vladimir Region. It will offer the first stage of in vitro fertilisation (IVF); gynaecological consultations, including for patients with reproductive health issues; as well as ultrasound diagnostics and laboratory tests. The clinic will work closely with MDMG’s clinics in Moscow and Yaroslavl where the second stage of IVF will take place. The opening of the new clinic in Vladimir will create intra-Group synergies and support the ramp-up of existing clinics in neighbouring regions.
The new clinic will be able to cater for up to 500 IFV cycles, including as part of the national Mandatory Health Insurance (MHI) programme, and up to 15,000 doctor visits per year. MDMG’s total investment in the Vladimir clinic was RUB 3.5 million.
Mother and Child Vladimir comprises a gynaecologist/fertility specialist’s office, an examination room with state-of-the-art ultrasound equipment, and a procedure room.
Mark Kurtser, CEO of MDMG, said:
“Wehave begun 2017 by opening a new clinic in the Vladimir region, where we see considerable potential, and are continuing to pursue our successful regional development strategy. As the undisputed leader in IVF in Russia, we are pleased that high-tech IFV services, including under the MHI programme, will become more accessible to residents of Vladimir region.
“As well as entering a market that is new for us, we believe that the synergies created will provide additional support for the results of our clinics in Moscow and Yaroslavl.
“I believe that this first step in the new year will set the pace for the Group’s operations in 2017, where we see good potential for our business to develop.”
For further information please contact:
Investors | Media |
Elena Romanova MD Medical Group Investments Plc Tel: +7 495 331 4120 | EM Sergii Pershyn: +1 929 855 8188 |
About MD Medical Group
MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 32 modern healthcare facilities, including 4 hospitals and 28 outpatient clinics in Moscow and Moscow region, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, and Vladimir.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Forward-Looking Statements:
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.